Kingswood Wealth Advisors LLC Increases Stock Holdings in GE HealthCare Technologies Inc. $GEHC

Kingswood Wealth Advisors LLC lifted its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) by 298.5% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 18,128 shares of the company’s stock after purchasing an additional 13,579 shares during the quarter. Kingswood Wealth Advisors LLC’s holdings in GE HealthCare Technologies were worth $1,487,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of GEHC. E Fund Management Hong Kong Co. Ltd. boosted its holdings in shares of GE HealthCare Technologies by 130.7% in the 3rd quarter. E Fund Management Hong Kong Co. Ltd. now owns 346 shares of the company’s stock worth $26,000 after purchasing an additional 196 shares during the period. Godsey & Gibb Inc. bought a new stake in shares of GE HealthCare Technologies during the 3rd quarter worth approximately $26,000. Optima Capital LLC bought a new stake in shares of GE HealthCare Technologies during the 4th quarter worth approximately $27,000. Maseco LLP bought a new stake in shares of GE HealthCare Technologies during the 4th quarter worth approximately $29,000. Finally, Oakworth Capital Inc. lifted its stake in shares of GE HealthCare Technologies by 1,876.2% during the 3rd quarter. Oakworth Capital Inc. now owns 415 shares of the company’s stock worth $31,000 after acquiring an additional 394 shares during the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Down 2.1%

Shares of NASDAQ GEHC opened at $69.89 on Friday. The company has a quick ratio of 1.13, a current ratio of 1.37 and a debt-to-equity ratio of 0.91. The business has a fifty day simple moving average of $74.88 and a two-hundred day simple moving average of $77.82. The firm has a market cap of $31.89 billion, a PE ratio of 15.33, a price-to-earnings-growth ratio of 1.57 and a beta of 1.17. GE HealthCare Technologies Inc. has a twelve month low of $64.77 and a twelve month high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last issued its earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share for the quarter, beating analysts’ consensus estimates of $1.40 by $0.04. The business had revenue of $5.70 billion during the quarter, compared to analyst estimates of $5.60 billion. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.GE HealthCare Technologies’s revenue was up 7.1% on a year-over-year basis. During the same period in the previous year, the company posted $1.45 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Analysts expect that GE HealthCare Technologies Inc. will post 5 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 3rd will be given a dividend of $0.035 per share. The ex-dividend date of this dividend is Thursday, April 2nd. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. GE HealthCare Technologies’s payout ratio is 3.07%.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on GEHC. The Goldman Sachs Group decreased their price target on GE HealthCare Technologies from $97.00 to $81.00 and set a “buy” rating for the company in a research note on Thursday, April 9th. Citigroup decreased their price target on GE HealthCare Technologies from $88.00 to $84.00 and set a “neutral” rating for the company in a research note on Wednesday, March 11th. Evercore raised their price target on GE HealthCare Technologies from $95.00 to $98.00 and gave the stock an “outperform” rating in a research note on Thursday, February 5th. Mizuho decreased their price target on GE HealthCare Technologies from $95.00 to $90.00 and set an “outperform” rating for the company in a research note on Monday, April 13th. Finally, Wells Fargo & Company raised their price target on GE HealthCare Technologies from $95.00 to $97.00 and gave the stock an “overweight” rating in a research note on Thursday, February 5th. Eight equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $89.77.

View Our Latest Report on GE HealthCare Technologies

GE HealthCare Technologies Profile

(Free Report)

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.

Featured Articles

• Five stocks we like better than GE HealthCare Technologies

Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report).